Private Banking
|
Professional Solutions
|
Investment Management
|
Investment Banking
|
About us
EN
Contact
Login
Van Lanschot Kempen Logo
Solutions
Sectors
Careers
Van Lanschot Kempen Logo
Login
Home
Investment Banking
Corporate Finance
Transactions
2016
Pharming July
Pharming
Pharming announced its intention to acquire all North American commercialisation rights to RUCONEST® from Valeant
Funded through a combination of debt and new equity capital
Kempen & Co acted as financial advisor to the Board of Supervisory Directors of Pharming